Report Detail

Pharma & Healthcare Global General Anesthetic for Surgery Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4744916
  • |
  • 28 September, 2026
  • |
  • Global
  • |
  • 109 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global General Anesthetic for Surgery market size was valued at US$ 4438 million in 2025 and is forecast to a readjusted size of US$ 5601 million by 2032 with a CAGR of 3.4% during review period.
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
The general anesthetic for surgery market is primarily driven by the increasing number of surgical procedures performed globally and the growing demand for safe and effective anesthesia to ensure patient comfort and successful surgical outcomes. General anesthesia plays a crucial role in inducing a reversible state of unconsciousness and analgesia during surgery, allowing surgeons to perform complex procedures with minimal patient discomfort. Moreover, advancements in anesthesia delivery systems and monitoring technologies contribute to the market"s growth by enhancing anesthesia administration precision and patient safety. However, the market also faces challenges, including the potential for adverse reactions and complications associated with general anesthesia, such as postoperative nausea and vomiting (PONV) or rare anesthetic-related reactions. Ensuring patient safety and minimizing the risk of adverse events remain key challenges for healthcare providers and anesthesiologists. Additionally, the availability and accessibility of anesthesia services in remote or underserved regions can be limited, hindering access to surgical care for some patients.
This report is a detailed and comprehensive analysis for global General Anesthetic for Surgery market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global General Anesthetic for Surgery market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global General Anesthetic for Surgery market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global General Anesthetic for Surgery market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global General Anesthetic for Surgery market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for General Anesthetic for Surgery
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global General Anesthetic for Surgery market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Yichang Humanwell, Nhwa, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
General Anesthetic for Surgery market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Other
Market segment by Application
Intravenous Anesthetics
Inhalational Anesthetics
Major players covered
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe General Anesthetic for Surgery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of General Anesthetic for Surgery, with price, sales quantity, revenue, and global market share of General Anesthetic for Surgery from 2021 to 2026.
Chapter 3, the General Anesthetic for Surgery competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the General Anesthetic for Surgery breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and General Anesthetic for Surgery market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of General Anesthetic for Surgery.
Chapter 14 and 15, to describe General Anesthetic for Surgery sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global General Anesthetic for Surgery Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Propofol
    • 1.3.3 Sevoflurane
    • 1.3.4 Remifentanil
    • 1.3.5 Etomidate
    • 1.3.6 Isoflurane
    • 1.3.7 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global General Anesthetic for Surgery Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Intravenous Anesthetics
    • 1.4.3 Inhalational Anesthetics
  • 1.5 Global General Anesthetic for Surgery Market Size & Forecast
    • 1.5.1 Global General Anesthetic for Surgery Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global General Anesthetic for Surgery Sales Quantity (2021-2032)
    • 1.5.3 Global General Anesthetic for Surgery Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Aspen Pharma
    • 2.1.1 Aspen Pharma Details
    • 2.1.2 Aspen Pharma Major Business
    • 2.1.3 Aspen Pharma General Anesthetic for Surgery Product and Services
    • 2.1.4 Aspen Pharma General Anesthetic for Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Aspen Pharma Recent Developments/Updates
  • 2.2 Fresenius-Kabi
    • 2.2.1 Fresenius-Kabi Details
    • 2.2.2 Fresenius-Kabi Major Business
    • 2.2.3 Fresenius-Kabi General Anesthetic for Surgery Product and Services
    • 2.2.4 Fresenius-Kabi General Anesthetic for Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Fresenius-Kabi Recent Developments/Updates
  • 2.3 AbbVie
    • 2.3.1 AbbVie Details
    • 2.3.2 AbbVie Major Business
    • 2.3.3 AbbVie General Anesthetic for Surgery Product and Services
    • 2.3.4 AbbVie General Anesthetic for Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 AbbVie Recent Developments/Updates
  • 2.4 Baxter Healthcare
    • 2.4.1 Baxter Healthcare Details
    • 2.4.2 Baxter Healthcare Major Business
    • 2.4.3 Baxter Healthcare General Anesthetic for Surgery Product and Services
    • 2.4.4 Baxter Healthcare General Anesthetic for Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Baxter Healthcare Recent Developments/Updates
  • 2.5 B.Braun
    • 2.5.1 B.Braun Details
    • 2.5.2 B.Braun Major Business
    • 2.5.3 B.Braun General Anesthetic for Surgery Product and Services
    • 2.5.4 B.Braun General Anesthetic for Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 B.Braun Recent Developments/Updates
  • 2.6 Maruishi
    • 2.6.1 Maruishi Details
    • 2.6.2 Maruishi Major Business
    • 2.6.3 Maruishi General Anesthetic for Surgery Product and Services
    • 2.6.4 Maruishi General Anesthetic for Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Maruishi Recent Developments/Updates
  • 2.7 Piramal
    • 2.7.1 Piramal Details
    • 2.7.2 Piramal Major Business
    • 2.7.3 Piramal General Anesthetic for Surgery Product and Services
    • 2.7.4 Piramal General Anesthetic for Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Piramal Recent Developments/Updates
  • 2.8 Hikma Pharmaceuticals
    • 2.8.1 Hikma Pharmaceuticals Details
    • 2.8.2 Hikma Pharmaceuticals Major Business
    • 2.8.3 Hikma Pharmaceuticals General Anesthetic for Surgery Product and Services
    • 2.8.4 Hikma Pharmaceuticals General Anesthetic for Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Hikma Pharmaceuticals Recent Developments/Updates
  • 2.9 Yichang Humanwell
    • 2.9.1 Yichang Humanwell Details
    • 2.9.2 Yichang Humanwell Major Business
    • 2.9.3 Yichang Humanwell General Anesthetic for Surgery Product and Services
    • 2.9.4 Yichang Humanwell General Anesthetic for Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Yichang Humanwell Recent Developments/Updates
  • 2.10 Nhwa
    • 2.10.1 Nhwa Details
    • 2.10.2 Nhwa Major Business
    • 2.10.3 Nhwa General Anesthetic for Surgery Product and Services
    • 2.10.4 Nhwa General Anesthetic for Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Nhwa Recent Developments/Updates
  • 2.11 Hengrui
    • 2.11.1 Hengrui Details
    • 2.11.2 Hengrui Major Business
    • 2.11.3 Hengrui General Anesthetic for Surgery Product and Services
    • 2.11.4 Hengrui General Anesthetic for Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hengrui Recent Developments/Updates
  • 2.12 Xi'an Libang
    • 2.12.1 Xi'an Libang Details
    • 2.12.2 Xi'an Libang Major Business
    • 2.12.3 Xi'an Libang General Anesthetic for Surgery Product and Services
    • 2.12.4 Xi'an Libang General Anesthetic for Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Xi'an Libang Recent Developments/Updates

3 Competitive Environment: General Anesthetic for Surgery by Manufacturer

  • 3.1 Global General Anesthetic for Surgery Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global General Anesthetic for Surgery Revenue by Manufacturer (2021-2026)
  • 3.3 Global General Anesthetic for Surgery Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of General Anesthetic for Surgery by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 General Anesthetic for Surgery Manufacturer Market Share in 2025
    • 3.4.3 Top 6 General Anesthetic for Surgery Manufacturer Market Share in 2025
  • 3.5 General Anesthetic for Surgery Market: Overall Company Footprint Analysis
    • 3.5.1 General Anesthetic for Surgery Market: Region Footprint
    • 3.5.2 General Anesthetic for Surgery Market: Company Product Type Footprint
    • 3.5.3 General Anesthetic for Surgery Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global General Anesthetic for Surgery Market Size by Region
    • 4.1.1 Global General Anesthetic for Surgery Sales Quantity by Region (2021-2032)
    • 4.1.2 Global General Anesthetic for Surgery Consumption Value by Region (2021-2032)
    • 4.1.3 Global General Anesthetic for Surgery Average Price by Region (2021-2032)
  • 4.2 North America General Anesthetic for Surgery Consumption Value (2021-2032)
  • 4.3 Europe General Anesthetic for Surgery Consumption Value (2021-2032)
  • 4.4 Asia-Pacific General Anesthetic for Surgery Consumption Value (2021-2032)
  • 4.5 South America General Anesthetic for Surgery Consumption Value (2021-2032)
  • 4.6 Middle East & Africa General Anesthetic for Surgery Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global General Anesthetic for Surgery Sales Quantity by Type (2021-2032)
  • 5.2 Global General Anesthetic for Surgery Consumption Value by Type (2021-2032)
  • 5.3 Global General Anesthetic for Surgery Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global General Anesthetic for Surgery Sales Quantity by Application (2021-2032)
  • 6.2 Global General Anesthetic for Surgery Consumption Value by Application (2021-2032)
  • 6.3 Global General Anesthetic for Surgery Average Price by Application (2021-2032)

7 North America

  • 7.1 North America General Anesthetic for Surgery Sales Quantity by Type (2021-2032)
  • 7.2 North America General Anesthetic for Surgery Sales Quantity by Application (2021-2032)
  • 7.3 North America General Anesthetic for Surgery Market Size by Country
    • 7.3.1 North America General Anesthetic for Surgery Sales Quantity by Country (2021-2032)
    • 7.3.2 North America General Anesthetic for Surgery Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe General Anesthetic for Surgery Sales Quantity by Type (2021-2032)
  • 8.2 Europe General Anesthetic for Surgery Sales Quantity by Application (2021-2032)
  • 8.3 Europe General Anesthetic for Surgery Market Size by Country
    • 8.3.1 Europe General Anesthetic for Surgery Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe General Anesthetic for Surgery Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific General Anesthetic for Surgery Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific General Anesthetic for Surgery Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific General Anesthetic for Surgery Market Size by Region
    • 9.3.1 Asia-Pacific General Anesthetic for Surgery Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific General Anesthetic for Surgery Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America General Anesthetic for Surgery Sales Quantity by Type (2021-2032)
  • 10.2 South America General Anesthetic for Surgery Sales Quantity by Application (2021-2032)
  • 10.3 South America General Anesthetic for Surgery Market Size by Country
    • 10.3.1 South America General Anesthetic for Surgery Sales Quantity by Country (2021-2032)
    • 10.3.2 South America General Anesthetic for Surgery Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa General Anesthetic for Surgery Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa General Anesthetic for Surgery Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa General Anesthetic for Surgery Market Size by Country
    • 11.3.1 Middle East & Africa General Anesthetic for Surgery Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa General Anesthetic for Surgery Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 General Anesthetic for Surgery Market Drivers
  • 12.2 General Anesthetic for Surgery Market Restraints
  • 12.3 General Anesthetic for Surgery Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of General Anesthetic for Surgery and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of General Anesthetic for Surgery
  • 13.3 General Anesthetic for Surgery Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 General Anesthetic for Surgery Typical Distributors
  • 14.3 General Anesthetic for Surgery Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on General Anesthetic for Surgery. Industry analysis & Market Report on General Anesthetic for Surgery is a syndicated market report, published as Global General Anesthetic for Surgery Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of General Anesthetic for Surgery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report